GB-115: activating anxiolytic application — RU2709013C1
Григорий Георгиевич Незнамов, Сергей Борисович Середенин, Ольга Анатольевна Дорофеева, Марианна Вячеславовна Метлина · 2019 · RU2709013C1 · patent family RU2709013C1
Published 2019-12-13.
Reported patent results
Narrative findings; numerical extraction incomplete
The clinical narrative describes reduced anxiety with improved sleep, energy and concentration.
GB-115 patent clinical anxiety observations and an illustrated 21-day case; full arm sizes and outcome-table values were not extracted.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Illustrative course | Improvement began toward the end of week 1; somatic/autonomic anxiety symptoms largely reduced by week 3 | Single selected case, not a controlled response rate · 21 days |
| Clinical scale narrative | Reduced mental and autonomic anxiety symptoms reported | The source cites before/after significance; exact values and denominators not entered |
| Reported tolerability | No listed sedative/muscle-relaxant or excessive-stimulation effects reported | Limited patent observation; not a comprehensive safety comparison |
Selected cases and incompletely extracted group data do not independently confirm modern trial efficacy. Related clinical publications may describe the same development program.
Source for the extracted data ↗ · Checked 2026-11-06
Patent claims and provenance
Use. The patent proposes GB-115 as an activating anxiolytic.
The granted use is not independent confirmation of all clinical anxiety or cognition claims.
- Publication
- RU2709013C1 ↗ · 2019-12-13
- Earliest priority / filing
- 2018-10-19 / 2018-10-19
- Original applicant / assignee
- Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова"
- Indexed status
- Not shown; official status unverified · checked 2026-11-06
- Patent family
- Grouping identifier unavailable · family publications are related filings, not independent studies.
Original title, inventors and related publications
Use of amide n-(6-phenylhexanoyl) glycyl-l-tryptophane (gb-115) as an agent having anxiolytic properties with an activating component
Inventors: Григорий Георгиевич Незнамов; Сергей Борисович Середенин; Ольга Анатольевна Дорофеева; Марианна Вячеславовна Метлина.
Molekul summary of the linked publication. Educational information, not medical advice. Seek qualified healthcare help for medical conditions.
Methods, limitations & source review
Study limitations
- The granted use is not independent confirmation of all clinical anxiety or cognition claims.
- Selected cases and incompletely extracted group data do not independently confirm modern trial efficacy. Related clinical publications may describe the same development program.
- Patents record claimed inventions and supporting disclosures. Publication or grant does not establish clinical efficacy, safety or marketing approval. Members of one patent family and related journal reports can describe the same experiments.
- Status labels are Google Patents index snapshots for the displayed publication or application; the record gives its source-check date. Official registers and every national family member have not been independently checked. These labels do not establish freedom to operate.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Document format: Original patent text and indexed metadata
Review depth: Claims, selected reported findings and limitations reviewed; supporting experiments not comprehensively appraised.
Related-report group: patent-family-RU2709013C1. Reports in this group are not assumed to be independent trials.
Source access and review scope
Original patent publication accessed through Google Patents. Claims, selected reported findings and source limitations checked. The results section identifies the examples, tables and any numerical extraction gaps. No complete experimental audit, prosecution review or legal claim construction was performed.
Recorded source-check date: 2026-11-06. This date does not imply a completed systematic review.
Source type: Patent publication
Citation and original source
Original source: Григорий Георгиевич Незнамов, Сергей Борисович Середенин, Ольга Анатольевна Дорофеева, Марианна Вячеславовна Метлина. GB-115: activating anxiolytic application — RU2709013C1 RU2709013C1 · patent family RU2709013C1 2019.
Molekul research summary: https://molekul.io/research/patent-ru2709013c1. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry